Stocks
ETFs
Options
Commodities
Crypto
Currency
Pro Newsletters
Research Tools
Daily Feeds
Calendars
Economic Indicators
Class Actions
Calculators
Education
About Us
Working with TipRanks
Follow Us
Applied DNA Sciences (APDN)
NASDAQ:APDN
APDN Stock Chart & Stats
Day’s Range― - ―
52-Week Range$0.12 - $14.40
Previous CloseN/A
Volume2.49M
Average Volume (3M)3.11M
Market Cap
$9.61M
Enterprise Value$826.63K
Total Cash (Recent Filing)N/A
Total Debt (Recent Filing)N/A
Price to Earnings (P/E)―
Beta3.45
Next Earnings
May 08, 2025EPS EstimateN/A
Next Dividend Ex-DateN/A
Dividend YieldN/A
Share Statistics
EPS (TTM)-5.72
Shares Outstanding55,188,522
10 Day Avg. Volume2,132,330
30 Day Avg. Volume3,105,851
Standard Deviation0.77
R-Squared0.00059
Alpha0.04
Financial Highlights & Ratios
PEG RatioN/A
Price to Book (P/B)N/A
Price to Sales (P/S)2.65
Price to Cash Flow (P/CF)-0.70
P/FCF Ratio0.00
Enterprise Value/Market Cap0.09
Enterprise Value/RevenueN/A
Enterprise Value/Gross Profit0.81
Enterprise Value/Ebitda-0.06
Forecast
1Y Price TargetN/A
Price Target UpsideN/A
Rating ConsensusN/A
Number of Analyst Covering0
---
Applied DNA Sciences News
PremiumCompany Announcements
Applied DNA Sciences Inc. Earnings Call Highlights Mixed Sentiment
PremiumCompany Announcements
Applied DNA Sciences Inc. Reports Restructuring and Revenue Growth
PremiumCompany Announcements
Applied DNA Sciences Advances in Genetic Medicines Market
PremiumCompany Announcements
Applied DNA Sciences Announces Leadership Changes and RestructuringPremiumPre-Earnings
Is APDN a Buy, Before Earnings?---
Ownership Overview
1.00%
Insiders
0.19% Mutual Funds
0.03% Other Institutional Investors
98.76% Public Companies and Individual Investors
Risk Analysis
Main Risk Category
Finance & CorporateFinancial and accounting risks. Risks related to the execution of corporate activity and strategy
APDN FAQ
What was Applied DNA Sciences’s price range in the past 12 months?
Applied DNA Sciences lowest stock price was $0.12 and its highest was $14.40 in the past 12 months.
What is Applied DNA Sciences’s market cap?
Applied DNA Sciences’s market cap is $9.61M.
When is Applied DNA Sciences’s upcoming earnings report date?
Applied DNA Sciences’s upcoming earnings report date is May 08, 2025 which is in 80 days.
How were Applied DNA Sciences’s earnings last quarter?
Applied DNA Sciences released its earnings results on Feb 13, 2025. The company reported -$0.56 earnings per share for the quarter, missing the consensus estimate of N/A by -$0.56.
Is Applied DNA Sciences overvalued?
According to Wall Street analysts Applied DNA Sciences’s price is currently Overvalued.
Does Applied DNA Sciences pay dividends?
Applied DNA Sciences does not currently pay dividends.
What is Applied DNA Sciences’s EPS estimate?
Applied DNA Sciences’s EPS estimate for its next earnings report is not yet available.
How many shares outstanding does Applied DNA Sciences have?
Applied DNA Sciences has 55,188,522 shares outstanding.
What happened to Applied DNA Sciences’s price movement after its last earnings report?
Applied DNA Sciences reported an EPS of -$0.56 in its last earnings report, missing expectations of N/A. Following the earnings report the stock price went same 0%.
Which hedge fund is a major shareholder of Applied DNA Sciences?
Currently, no hedge funds are holding shares in APDN
---
Company Description
Applied DNA Sciences
Applied DNA Sciences, Inc. engages in the provision of security solutions. It offers molecular-based technology solutions and services that can help protect products, brands, supply chains, and intellectual property of companies, governments, and consumers from theft, counterfeiting, fraud, and diversion. Its products include the following brands: Applied DNA Sciences, SigNature, molecular tags, SigNature, T molecular tags, fiberTyping, DNAnet, digitalDNA, SigNify, BackTrac, Beacon, and CertainT. The company was founded in 1983 and is headquartered in Stony Brook, NY.
---
APDN Earnings Call
Q1 2025
0:00 / 0:00
Earnings Call Sentiment|Neutral
The earnings call presented a mixed outlook. While there were notable achievements in revenue growth, operational improvements, and strategic refocus on LineaRx, the exit from a business segment, workforce reduction, and ongoing financial challenges cast a shadow on the overall performance.Read More>---
APDN Stock 12 Month Forecast
Average Price Target
―Technical Analysis
Best Analysts Covering APDN
1 Year
1 Year Success Rate
0/14 ratings generated profit
1 Year Average Return
-73.27%
reiterated a buy rating 8 months ago
Copying Yi Chen's trades and holding each position for 1 Year would result in 0.00% of your transactions generating a profit, with an average return of -73.27% per trade.
---